Pizarra, Teodoro S.
HRN: 01-77-72 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2023
CEFTRIAXONE 1G (VIAL)
06/20/2023
06/26/2023
IV
2g
OD
Tonsillopharyngitis
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes